Gene · 8794
Papers1,743
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,743
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring the ability of machine learning-based virtual screening models to identify the functional groups responsible for binding. | J Cheminform | 2023 | 37726844 | PubTator, text mining | PubMed |
| The early-phase transcriptome and the clinical efficacy analysis in three modes of subcutaneous immunotherapy for allergic rhinitis. | World Allergy Organ J | 2023 | 37701629 | PubTator, text mining | PubMed |
| The Relationship Between Dietary Inflammatory Index and All-Cause, Cardiovascular Disease-Related, and Cancer-Related Mortality. | J Multidiscip Healthc | 2023 | 37667797 | PubTator, text mining | PubMed |
| Design, synthesis, in vitro anticancer, molecular docking and SAR studies of new series of pyrrolo[2,3-d]pyrimidine derivatives. | BMC Chem | 2023 | 37641068 | PubTator, text mining | PubMed |
| Anti-Cancer Effect of Neural Stem Cells Transfected with Carboxylesterase and sTRAIL Genes in Animals with Brain Lesions of Lung Cancer. | Pharmaceuticals (Basel) | 2023 | 37631070 | PubTator, text mining | PubMed |
| Autoimmune Heart Disease: A Comprehensive Summary for Forensic Practice. | Medicina (Kaunas) | 2023 | 37629654 | PubTator, text mining | PubMed |
| Research Progress of DcR3 in the Diagnosis and Treatment of Sepsis. | Int J Mol Sci | 2023 | 37629097 | PubTator, text mining | PubMed |
| Development of a Novel CD26-Targeted Chimeric Antigen Receptor T-Cell Therapy for CD26-Expressing T-Cell Malignancies. | Cells | 2023 | 37626869 | PubTator, text mining | PubMed |
| TRAIL and its receptors in cardiac diseases. | Front Physiol | 2023 | 37621762 | PubTator, text mining | PubMed |
| Maternal pre-pregnancy BMI, offspring epigenome-wide DNA methylation, and childhood obesity: findings from the Boston Birth Cohort. | BMC Med | 2023 | 37612641 | PubTator, text mining | PubMed |
| Dose-related immunomodulatory effects of recombinant TRAIL in the tumor immune microenvironment. | J Exp Clin Cancer Res | 2023 | 37605148 | PubTator, text mining | PubMed |
| Preparation of honokiol-loaded titanium dioxide nanotube drug delivery system and its effect on CAL-27 cells. | Front Bioeng Biotechnol | 2023 | 37600298 | PubTator, text mining | PubMed |
| Core Fucosylation Mediated by the FucT-8 Enzyme Affects TRAIL-Induced Apoptosis and Sensitivity to Chemotherapy in Human SW480 and SW620 Colorectal Cancer Cells. | Int J Mol Sci | 2023 | 37569254 | PubTator, text mining | PubMed |
| Nonviral base editing of KCNJ13 mutation preserves vision in a model of inherited retinal channelopathy. | J Clin Invest | 2023 | 37561581 | PubTator, text mining | PubMed |
| Pan-integrin inhibitor GLPG-0187 promotes T-cell killing of mismatch repair-deficient colorectal cancer cells by suppression of SMAD/TGF-β signaling. | Am J Cancer Res | 2023 | 37559992 | PubTator, text mining | PubMed |
| Structural-and-dynamical similarity predicts compensatory brain areas driving the post-lesion functional recovery mechanism. | Cereb Cortex Commun | 2023 | 37559936 | PubTator, text mining | PubMed |
| Anti-Inflammatory Effects of Dietary Polyphenols through Inhibitory Activity against Metalloproteinases. | Molecules | 2023 | 37513300 | PubTator, text mining | PubMed |
| From Teeth to Therapy: A Review of Therapeutic Potential within the Secretome of Stem Cells from Human Exfoliated Deciduous Teeth. | Int J Mol Sci | 2023 | 37511524 | PubTator, text mining | PubMed |
| Plasma TRAIL and ANXA1 in diagnosis and prognostication of pulmonary arterial hypertension. | Pulm Circ | 2023 | 37502145 | PubTator, text mining | PubMed |
| A perspective on the sharing of docking data. | Data Brief | 2023 | 37492229 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8794/papers?page=6